18 May 2022 | BST (UTC+1)

Peter Joyce

Chief Executive Officer
Grey Wolf Therapeutics
Peter Joyce
Peter is founder and Chief Executive Officer of Grey Wolf, setting up the company in 2017 with Tom McCarthy. Peter has over 15 years of experience in biomedical research leading drug discovery projects across disease areas. Prior to Grey Wolf he was at Vertex Pharmaceuticals for 5 and a half years, where he led drug discovery projects and had responsibility for leading a number of target identification teams, and before Vertex he was a post-doc at the MRC. Peter holds a PhD in Biochemistry and Molecular Genetics from the University of Bristol and a BSc in Biochemistry.

Sessions

No data was found

Other Speakers

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure